Reexamination of the Role of Ubiquitin-like Modifier ISG15 in the Phenotype of UBP43-deficient Mice

Overview

Journal Mol Cell Biol

Specialty Cell Biology

Date 2005 Nov 30

PMID 16314524

Citations 51

Authors

Klaus-Peter Knobeloch

Olaf Utermohlen

Agnes Kisser

Marco Prinz

Ivan Horak

Affiliations

Soon will be listed here.

Abstract

UBP43/USP18 was described as a specific protease that removes conjugated ubiquitin-like modifier ISG15 from target proteins. The severe phenotype of UBP43(-/-) mice characterized by premature death, brain cell injury, and deregulated STAT1 signaling was ascribed to an enhanced conjugation of ISG15. In contrast, no phenotypic changes were detected in ISG15(-/-) mice. To verify the role of ISG15 in the phenotype of UBP43(-/-) mice, we employed mice deficient for both ISG15 and UBP43. Here, we show that the phenotype of UBP43(-/-) mice was not rescued by the absence of ISG15, as evident from unchanged mortality, neurological symptoms, and occurrence of hydrocephalus. Also, the reported hypersensitivity of UBP43(-/-) mice to an interferon inducer, poly(I . C), was ISG15 independent. Furthermore, no evidence for a role of ISG15 in the modulation of STAT1 signaling or in the resistance against lymphocytic choriomeningitis virus and vesicular stomatitis virus was found. Presented results clearly demonstrate that the phenotypic alterations of UBP43(-/-) mice are not caused by the lack of ISG15 deconjugation and must be due to another, non-ISG15-mediated molecular mechanism.

Citing Articles

Type I interferon regulation by USP18 is a key vulnerability in cancer.

Jove V, Wheeler H, Lee C, Healy D, Levine K, Ralph E iScience. 2024; 27(4):109593.

PMID: 38632987 PMC: 11022047. DOI: 10.1016/j.isci.2024.109593.

In the moonlight: non-catalytic functions of ubiquitin and ubiquitin-like proteases.

Campos Alonso M, Knobeloch K Front Mol Biosci. 2024; 11:1349509.

PMID: 38455765 PMC: 10919355. DOI: 10.3389/fmolb.2024.1349509.

ISGylation-independent protection of cell growth by USP18 following interferon stimulation.

Clancy A, Rusilowicz-Jones E, Wallace I, Swatek K, Urbe S, Clague M Biochem J. 2023; 480(19):1571-1581.

PMID: 37756534 PMC: 10586769. DOI: 10.1042/BCJ20230301.

ISG15: its roles in SARS-CoV-2 and other viral infections.

Sarkar L, Liu G, Gack M Trends Microbiol. 2023; 31(12):1262-1275.

PMID: 37573184 PMC: 10840963. DOI: 10.1016/j.tim.2023.07.006.

RelB-deficient autoinflammatory pathology presents as interferonopathy, but in mice is interferon-independent.

Navarro H, Liu Y, Fraser A, Lefaudeux D, Chia J, Vong L J Allergy Clin Immunol. 2023; 152(5):1261-1272.

PMID: 37460023 PMC: 10858800. DOI: 10.1016/j.jaci.2023.06.024.

References

Yuan W, KRUG R . Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J. 2001; 20(3):362-71. PMC: 133459. DOI: 10.1093/emboj/20.3.362. View

Ritchie K, Hahn C, Kim K, Yan M, Rosario D, Li L . Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection. Nat Med. 2004; 10(12):1374-8. DOI: 10.1038/nm1133. View

Malakhov M, Malakhova O, Kim K, Ritchie K, Zhang D . UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J Biol Chem. 2002; 277(12):9976-81. DOI: 10.1074/jbc.M109078200. View

Ritchie K, Malakhov M, Hetherington C, Zhou L, Little M, Malakhova O . Dysregulation of protein modification by ISG15 results in brain cell injury. Genes Dev. 2002; 16(17):2207-12. PMC: 186669. DOI: 10.1101/gad.1010202. View

Malakhova O, Yan M, Malakhov M, Yuan Y, Ritchie K, Kim K . Protein ISGylation modulates the JAK-STAT signaling pathway. Genes Dev. 2003; 17(4):455-60. PMC: 195994. DOI: 10.1101/gad.1056303. View

Malakhov M, Kim K, Malakhova O, Jacobs B, Borden E, Zhang D . High-throughput immunoblotting. Ubiquitiin-like protein ISG15 modifies key regulators of signal transduction. J Biol Chem. 2003; 278(19):16608-13. DOI: 10.1074/jbc.M208435200. View

Pickart C . Back to the future with ubiquitin. Cell. 2004; 116(2):181-90. DOI: 10.1016/s0092-8674(03)01074-2. View

Moller Martensen P, Justesen J . Small ISGs coming forward. J Interferon Cytokine Res. 2004; 24(1):1-19. DOI: 10.1089/107999004772719864. View

Zhao C, Beaudenon S, Kelley M, Waddell M, Yuan W, Schulman B . The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like protein. Proc Natl Acad Sci U S A. 2004; 101(20):7578-82. PMC: 419648. DOI: 10.1073/pnas.0402528101. View

10.

Ritchie K, Zhang D . ISG15: the immunological kin of ubiquitin. Semin Cell Dev Biol. 2004; 15(2):237-46. DOI: 10.1016/j.semcdb.2003.12.005. View

11.

Farrell P, Broeze R, Lengyel P . Accumulation of an mRNA and protein in interferon-treated Ehrlich ascites tumour cells. Nature. 1979; 279(5713):523-5. DOI: 10.1038/279523a0. View

12.

Korant B, BLOMSTROM D, Jonak G, KNIGHT Jr E . Interferon-induced proteins. Purification and characterization of a 15,000-dalton protein from human and bovine cells induced by interferon. J Biol Chem. 1984; 259(23):14835-9. View

13.

Haas A, Ahrens P, Bright P, ANKEL H . Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin. J Biol Chem. 1987; 262(23):11315-23. View

14.

Loeb K, Haas A . The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins. J Biol Chem. 1992; 267(11):7806-13. View

15.

Gegin C, Lehmann-Grube F . Control of acute infection with lymphocytic choriomeningitis virus in mice that cannot present an immunodominant viral cytotoxic T lymphocyte epitope. J Immunol. 1992; 149(10):3331-8. View

16.

Narasimhan J, POTTER J, Haas A . Conjugation of the 15-kDa interferon-induced ubiquitin homolog is distinct from that of ubiquitin. J Biol Chem. 1996; 271(1):324-30. DOI: 10.1074/jbc.271.1.324. View

17.

Osiak A, Utermohlen O, Niendorf S, Horak I, Knobeloch K . ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus. Mol Cell Biol. 2005; 25(15):6338-45. PMC: 1190360. DOI: 10.1128/MCB.25.15.6338-6345.2005. View

18.

Zhao C, Denison C, Huibregtse J, Gygi S, Krug R . Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci U S A. 2005; 102(29):10200-5. PMC: 1177427. DOI: 10.1073/pnas.0504754102. View

19.

Hershko A, Ciechanover A . The ubiquitin system. Annu Rev Biochem. 1998; 67:425-79. DOI: 10.1146/annurev.biochem.67.1.425. View

20.

Hamerman J, Hayashi F, Schroeder L, Gygi S, Haas A, Hampson L . Serpin 2a is induced in activated macrophages and conjugates to a ubiquitin homolog. J Immunol. 2002; 168(5):2415-23. DOI: 10.4049/jimmunol.168.5.2415. View